Minimally Invasive Treatment Of Lung Cancer Market Expected to Achieve 9.3% CAGR by 2029: Growth Forecast Insights

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Minimally Invasive Treatment Of Lung Cancer Market Size By 2025?
The market size for minimally invasive treatment of lung cancer has seen robust growth in recent years. An upward trajectory is expected, moving from $3.06 billion in 2024 to $3.35 billion in 2025, with a compound annual growth rate (CAGR) of 9.7%. The growth witnessed in the historic period can be ascribed to factors such as the escalating prevalence of lung cancer, increased awareness about minimally invasive techniques, a surge in the geriatric population, adoption of early detection methods, and growth in healthcare infrastructure.

How Big Is the Minimally Invasive Treatment Of Lung Cancer Market Size Expected to Grow by 2029?
The market for minimally invasive lung cancer treatment is projected to experience significant expansion in the coming years, with an estimated value of $4.78 billion in 2029, progressing at a compound annual growth rate (CAGR) of 9.3%. This predicted growth may be due to a surge in demand for day surgery procedures, an increase in funding for dedicated lung cancer facilities, the broader accessibility of minimally invasive treatment alternatives, government schemes advocating for enhanced healthcare, and an emphasis on minimizing post-surgery complications. The forthcoming period is expected to see major trends such as advancements in surgical tool technology, innovative patient monitoring systems, the emergence of precision therapy techniques, research into less invasive procedures, and the incorporation of artificial intelligence into treatment planning.

View the full report here:
https://www.thebusinessresearchcompany.com/report/minimally-invasive-treatment-of-lung-cancer-global-market-report

Which Key Market Drivers Powering Minimally Invasive Treatment Of Lung Cancer Market Expansion and Growth?
The growth of the minimally invasive treatment of lung cancer market is expected to be fuelled by the rising incidence of lung cancer. This form of cancer, which originates in the lungs, sees uncontrolled cell growth and is largely caused by an upsurge in tobacco smoking. This habit heightens the possibility of unchecked cell expansion and tumor growth. Minimally invasive treatment serves as a beneficial alternative for lung cancer patients as it targets, removes or destroys tumors through small incisions or imaging-guided probes. This cuts down recovery time, limits harm to healthy lung tissue, reduces potential complications, and enables patients to get back to their daily routines more swiftly. For example, data from the Centers for Disease Control and Prevention, a US-based government agency, revealed that in 2022, the US saw 218,893 new lung cancer cases, resulting in 131,584 fatalities in the nation. Consequently, the growing incidence of lung cancer is fuelling the expansion of the minimally invasive treatment of lung cancer market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27349&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Minimally Invasive Treatment Of Lung Cancer Market?
Leading businesses in the lung cancer minimally invasive treatment market are putting efforts into advancing technologies such as fluoroscopic navigation platforms. These platforms aim to improve precision and provide localized lung therapy. Medical imaging systems known as fluoroscopic navigation platforms merge real-time fluoroscopy with navigation technology, accurately steering instruments to targeted lung areas. This technique facilitates minimally invasive biopsies and treats hard-to-reach lesions while lowering complication risks. For example, in July 2022, Medtronic plc, a medical technology company based in Ireland, made a world-first announcement about an endoluminal lung ablation procedure using the ILLUMISITE. The minimally invasive technique, manually performed by physicians in Hong Kong, utilized the ILLUMISITE platform for precise navigation through a patient's lungs, following a personalized virtual pathway built on their CT scan. The platform's navigation catheter played a crucial role in directing the bronchoscope to the lung lesion, where a specialized ablation catheter provided targeted therapy. This breakthrough has set a significant precedent in lung mass diagnosis and treatment, integrating exact navigation with localized ablation technology.

What Are the Emerging Segments in the Minimally Invasive Treatment Of Lung Cancer Market?
The minimally invasive treatment of lung cancer market covered in this report is segmented

1) By Type: Lung Tumor Ablation, Lung Tumor Embolization
2) By Stage: Stage I, Stage II, Stage III, Stage IV
3) By Age Group: Under 30 Years, 31 To 45 Years, 46 To 60 Years
4) By End-User: Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics, Research Institutions

Subsegments:
1) By Lung Tumor Ablation: Radiofrequency Ablation, Microwave Ablation, Cryoablation, Laser Ablation
2) By Lung Tumor Embolization: Bronchial Artery Embolization, Pulmonary Artery Embolization, Chemoembolization, Radioembolization

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=27349&type=smp

Who Are the Global Leaders in the Minimally Invasive Treatment Of Lung Cancer Market?
Major companies operating in the minimally invasive treatment of lung cancer market are Johnson & Johnson, Medtronic plc, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Intuitive Surgical Inc., Weill Cornell Medicine, Accuray Incorporated, Richard Wolf GmbH, AngioDynamics Inc., CMR Surgical Ltd., Biodesix Inc., Guangzhou Geyi Medical Instrument Co. Ltd., Quantum Surgical SA, Scanlan International Inc., RZ Medizintechnik GmbH & Co. KG, August Reuchlen GmbH, SBH Surgical GmbH & Co. KG, Geister Medizintechnik GmbH.

Which are the Top Profitable Regional Markets for the Minimally Invasive Treatment Of Lung Cancer Industry?
North America was the largest region in the minimally invasive treatment of lung cancer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive treatment of lung cancer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=27349

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.